Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
EVENT DATE
May 2017
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031    

Contacts

2479 East Bayshore Road Suite 200 Palo Alto , California 94303

General

Referral
Tel: (888) 717-2436

Event Manager

General

Venue

Venue TBD Washington , District of Columbia
Google Map

FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

Overview

Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.

The following steps to establish the appropriate manufacturing environment for phase 1 investigational drugs should be taken:

  • A comprehensive and systematic evaluation of the manufacturing setting (i.e., product environment, equipment, process, personnel, materials) to identify potential hazards
  • Appropriate actions prior to and during manufacturing to eliminate or mitigate potential hazards to safeguard the quality of the phase 1 investigational drug

Review the FDA recommendations and requirements for implementing a compliant program for the phase 1 clinical program.

Course benefit:
This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Regulatory strategies and logistical considerations for early development stage product, including vendor selection and management, stability, labeling, and documentation requirements will also be reviewed and explored.

Learning Objectives:
To gain an understanding of the requirements for drugs entering into phase 1 clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing manufacturing and quality strategies to meet FDA requirements.

Who will Benefit:
Directors
Manager
Supervisors
Lead workers in Regulatory Affairs Quality Assurance and Quality Control
Workers who will prepare GMP documents for early phase products

Note:
Use coupon code NB5SQH8N and get 10% off on registration.

For Registration:
http://www.complianceonline.com/fda-gmp-expectations-phase-i-first-in-man-clinical-trials-iso-9001-2015-qms-cmc-seminar-training-80366SEM-prdsm?channel=eventsinamerica

Notes:
Sponsorship Details:

RELATED EVENTS +

MORE events +

Display Makers +

Promo Makers +

Other Services Providers

© copyright since 2008 All Rights Reserved eventsinamerica.com